1. Home
  2. CERS vs BBNX Comparison

CERS vs BBNX Comparison

Compare CERS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$3.12

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.49

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CERS
BBNX
Founded
1991
2015
Country
United States
United States
Employees
N/A
423
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.1M
493.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CERS
BBNX
Price
$3.12
$16.49
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$23.80
AVG Volume (30 Days)
2.9M
1.1M
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
N/A
EPS
N/A
N/A
Revenue
$51,326,000.00
N/A
Revenue This Year
$19.95
$34.90
Revenue Next Year
$8.84
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
30.68
N/A
52 Week Low
$1.15
$8.80
52 Week High
$3.21
$32.71

Technical Indicators

Market Signals
Indicator
CERS
BBNX
Relative Strength Index (RSI) 69.04 67.27
Support Level $2.37 $16.02
Resistance Level N/A $32.52
Average True Range (ATR) 0.17 1.07
MACD 0.04 0.16
Stochastic Oscillator 94.34 89.90

Price Performance

Historical Comparison
CERS
BBNX

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: